Intas Pharma may reconsider proposed IPO, could look at PE deal to give ChrysCap part exit
30 September, 2013
Intas Pharmaceuticals Ltd, which had filed its draft red-herring prospectus (DRHP) with SEBI for a proposed initial public offering (IPO) three months ago to give part exit to existing investor ...
TO READ THE FULL STORY
The only platform exclusively covering Private Investments in India.
Exclusive reporting, expert analyses and commentary on PE/VC/M&A deals and dealmakers
Daily, weekly and monthly curated newsletters on the alternative investment ecosystem in India
Participation in VCCircle Marquee events at concessional rates
Latest VCCEdge annual, quarterly and industry reports
Comprehensive | Accurate | Unbiased | Impeccably sourced